Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Early notable gainers among liquid option names on May 22nd » 09:55
05/22/20
05/22
09:55
05/22/20
09:55
NEM

Newmont

$63.90 /

+0.37 (+0.58%)

, NVDA

Nvidia

$350.67 /

-0.34 (-0.10%)

, BSX

Boston Scientific

$35.53 /

+0.72 (+2.07%)

, SIG

Signet Jewelers

$10.20 /

+0.04 (+0.39%)

, A

Agilent

$87.10 /

+6.26 (+7.74%)

Notable gainers among…

Notable gainers among liquid option names this morning include Agilent (A) $86.70 +5.95, Signet Jewelers (SIG) $10.58 +0.42, Boston Scientific (BSX) $35.89 +1.10, NVIDIA (NVDA) $358.58 +7.57, and Newmont Mining (NEM) $64.72 +1.24.

ShowHide Related Items >><<
SIG Signet Jewelers
$10.20 /

+0.04 (+0.39%)

NVDA Nvidia
$350.67 /

-0.34 (-0.10%)

NEM Newmont
$63.90 /

+0.37 (+0.58%)

BSX Boston Scientific
$35.53 /

+0.72 (+2.07%)

A Agilent
$87.10 /

+6.26 (+7.74%)

NEM Newmont
$63.90 /

+0.37 (+0.58%)

05/18/20 Standpoint Research
Newmont downgraded to Hold from Buy at Standpoint Research
05/06/20 Deutsche Bank
Newmont price target raised to $70 from $54 at Deutsche Bank
05/06/20 Citi
Newmont price target raised to $70 from $46 at Citi
04/16/20 JPMorgan
Newmont price target raised to $70 from $61 at JPMorgan
NVDA Nvidia
$350.67 /

-0.34 (-0.10%)

05/22/20 JPMorgan
Nvidia price target raised to $405 from $305 at JPMorgan
05/22/20 Rosenblatt
Nvidia price target raised to $400 from $340 at Rosenblatt
05/22/20 Raymond James
Nvidia price target raised to $370 from $330 at Raymond James
05/22/20 Craig-Hallum
Nvidia price target raised to $335 from $300 at Craig-Hallum
BSX Boston Scientific
$35.53 /

+0.72 (+2.07%)

05/10/20 Piper Sandler
FLX to further strengthen Boston category leadership in LAAC, says Piper Sandler
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
04/22/20 SVB Leerink
Boston Scientific downgraded to Market Perform at SVB Leerink on slower recovery
04/22/20 SVB Leerink
Boston Scientific downgraded to Market Perform from Outperform at SVB Leerink
SIG Signet Jewelers
$10.20 /

+0.04 (+0.39%)

03/27/20 BofA
Signet Jewelers downgraded to Underperform from Neutral at BofA
03/27/20 BofA
Signet Jewelers downgraded to Underperform from Neutral at BofA
01/17/20 Citi
Signet Jewelers price target raised to $22 from $13 at Citi
01/02/20
Fly Intel: Top five analyst downgrades
A Agilent
$87.10 /

+6.26 (+7.74%)

05/22/20 Cowen
Agilent price target raised to $95 from $80 at Cowen
03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
SIG Signet Jewelers
$10.20 /

+0.04 (+0.39%)

NVDA Nvidia
$350.67 /

-0.34 (-0.10%)

NEM Newmont
$63.90 /

+0.37 (+0.58%)

BSX Boston Scientific
$35.53 /

+0.72 (+2.07%)

A Agilent
$87.10 /

+6.26 (+7.74%)

  • 22
    May
NVDA Nvidia
$350.67 /

-0.34 (-0.10%)

NEM Newmont
$63.90 /

+0.37 (+0.58%)

BSX Boston Scientific
$35.53 /

+0.72 (+2.07%)

A Agilent
$87.10 /

+6.26 (+7.74%)

SIG Signet Jewelers
$10.20 /

+0.04 (+0.39%)

NVDA Nvidia
$350.67 /

-0.34 (-0.10%)

BSX Boston Scientific
$35.53 /

+0.72 (+2.07%)

A Agilent
$87.10 /

+6.26 (+7.74%)

SIG Signet Jewelers
$10.20 /

+0.04 (+0.39%)

NVDA Nvidia
$350.67 /

-0.34 (-0.10%)

NEM Newmont
$63.90 /

+0.37 (+0.58%)

BSX Boston Scientific
$35.53 /

+0.72 (+2.07%)

A Agilent
$87.10 /

+6.26 (+7.74%)

Recommendations
Agilent price target raised to $95 from $80 at Cowen » 07:48
05/22/20
05/22
07:48
05/22/20
07:48
A

Agilent

$80.84 /

-0.83 (-1.02%)

Cowen analyst Doug…

Cowen analyst Doug Schenkel raised the firm's price target on Agilent to $95 from $80 and keeps an Outperform rating on the shares. The analyst said the company posted a strong top and bottom beat, aided by resilient pharma trends and a significant bounce in China. Schenkel said the long-term outlook remains exciting.

ShowHide Related Items >><<
A Agilent
$80.84 /

-0.83 (-1.02%)

A Agilent
$80.84 /

-0.83 (-1.02%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
A Agilent
$80.84 /

-0.83 (-1.02%)

A Agilent
$80.84 /

-0.83 (-1.02%)

A Agilent
$80.84 /

-0.83 (-1.02%)

A Agilent
$80.84 /

-0.83 (-1.02%)

On The Fly
Fly Intel: After-Hours Movers » 19:01
05/21/20
05/21
19:01
05/21/20
19:01
PANW

Palo Alto Networks

$229.36 /

-4.89 (-2.09%)

, RAMP

LiveRamp

$38.70 /

-0.16 (-0.41%)

, CRMT

America's Car-Mart

$73.77 /

+2.825 (+3.98%)

, ELF

e.l.f. Beauty

$14.56 /

+0.34 (+2.39%)

, A

Agilent

$80.84 /

-0.83 (-1.02%)

, SPLK

Splunk

$163.27 /

+0.11 (+0.07%)

, DECK

Deckers Brands

$167.93 /

+5.83 (+3.60%)

, PRSP

Perspecta

$22.93 /

-0.4 (-1.71%)

, PLUS

ePlus

$76.14 /

+4.14 (+5.75%)

, NAVB

Navidea

$1.32 /

+0.06 (+4.76%)

, USFD

US Foods

$18.56 /

-0.24 (-1.28%)

, NYMT

New York Mortgage

$2.04 /

+0.105 (+5.43%)

, AGYS

Agilysys

$20.11 /

+0.79 (+4.09%)

, HPE

HP Enterprise

$10.35 /

+0.07 (+0.68%)

, LGF.A

Lionsgate

$8.61 /

+0.13 (+1.53%)

, ROST

Ross Stores

$97.01 /

+6.1 (+6.71%)

, INTU

Intuit

$290.30 /

-0.4 (-0.14%)

, CHUY

Chuy's

$16.13 /

+0.09 (+0.56%)

, NVDA

Nvidia

$351.01 /

-7.78 (-2.17%)

, SNDX

Syndax

$20.51 /

+0.34 (+1.69%)

, GERN

Geron

$1.95 /

+0.06 (+3.17%)

, CFRX

ContraFect

$5.38 /

-0.22 (-3.93%)

, DSS

Document Security

$8.50 /

+0.22 (+2.66%)

, H

Hyatt

$53.45 /

-0.49 (-0.91%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
USFD US Foods
$18.56 /

-0.24 (-1.28%)

SPLK Splunk
$163.27 /

+0.11 (+0.07%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

RAMP LiveRamp
$38.70 /

-0.16 (-0.41%)

PRSP Perspecta
$22.93 /

-0.4 (-1.71%)

PLUS ePlus
$76.14 /

+4.14 (+5.75%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

NAVB Navidea
$1.32 /

+0.06 (+4.76%)

LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

GERN Geron
$1.95 /

+0.06 (+3.17%)

ELF e.l.f. Beauty
$14.56 /

+0.34 (+2.39%)

DSS Document Security
$8.50 /

+0.22 (+2.66%)

DECK Deckers Brands
$167.93 /

+5.83 (+3.60%)

CRMT America's Car-Mart
$73.77 /

+2.825 (+3.98%)

CHUY Chuy's
$16.13 /

+0.09 (+0.56%)

CFRX ContraFect
$5.38 /

-0.22 (-3.93%)

AGYS Agilysys
$20.11 /

+0.79 (+4.09%)

A Agilent
$80.84 /

-0.83 (-1.02%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

05/20/20 Wells Fargo
Palo Alto Networks price target raised to $250 from $225 at Wells Fargo
05/20/20 Monness Crespi
Palo Alto Networks price target raised to $255 from $210 at Monness Crespi
05/19/20 Dougherty
Dougherty sees Palo Alto set up for rebound, upgrades to Buy
05/19/20 Dougherty
Palo Alto Networks upgraded to Buy from Neutral at Dougherty
RAMP LiveRamp
$38.70 /

-0.16 (-0.41%)

04/27/20 Needham
LiveRamp price target lowered to $57 from $70 at Needham
04/21/20 Berenberg
LiveRamp initiated with a Buy at Berenberg
03/13/20 Stephens
LiveRamp weakness creates 'real opportunity,' says Stephens
01/26/20 First Analysis
First Analysis sees continued top-line momentum in 2020 for LiveRamp
CRMT America's Car-Mart
$73.77 /

+2.825 (+3.98%)

03/27/20 Stephens
America's Car-Mart upgraded to Overweight from Equal Weight at Stephens
02/13/20 Janney Montgomery Scott
America's Car-Mart downgraded to Neutral from Buy at Janney Montgomery Scott
ELF e.l.f. Beauty
$14.56 /

+0.34 (+2.39%)

04/08/20 Piper Sandler
Piper lays out winners and losers in survey of 5,200 teens
03/18/20 DA Davidson
e.l.f. Beauty price target lowered to $12 from $24.50 at DA Davidson
02/06/20 Piper Sandler
e.l.f. Beauty price target raised to $23 from $19 at Piper Sandler
02/04/20
Fly Intel: Top five analyst upgrades
A Agilent
$80.84 /

-0.83 (-1.02%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
SPLK Splunk
$163.27 /

+0.11 (+0.07%)

05/14/20 Cleveland Research
Splunk estimates at risk amid enterprise weakness, says Cleveland Research
04/27/20 Needham
Splunk price target lowered to $168 from $181 at Needham
04/24/20 Cowen
Splunk downgraded to Market Perform at Cowen
04/24/20 Cowen
Splunk downgraded to Market Perform from Outperform at Cowen
DECK Deckers Brands
$167.93 /

+5.83 (+3.60%)

05/18/20 Wedbush
Deckers Brands price target raised to $155 from $145 at Wedbush
05/15/20 Pivotal Research
Deckers Brands price target lowered to $165 from $217 at Pivotal Research
05/14/20 Wells Fargo
Wells Fargo downgrades Steven Madden to Underweight on brand weakness
04/28/20 BTIG
Deckers Brands initiated with a Buy at BTIG
PRSP Perspecta
$22.93 /

-0.4 (-1.71%)

04/02/20 Wells Fargo
Perspecta price target lowered to $18.50 from $26 at Wells Fargo
03/30/20 William Blair
Perspecta initiated with a Market Perform at William Blair
03/25/20 Wells Fargo
Good news for government contractors in COVID -19 bill, says Wells Fargo
02/25/20 Morgan Stanley
Morgan Stanley upgrades Perspecta to Equal Weight on overhang removal
PLUS ePlus
$76.14 /

+4.14 (+5.75%)

02/11/20 Berenberg
ePlus upgraded to Buy from Hold at Berenberg
02/06/20 Sidoti
ePlus upgraded to Buy after earnings at Sidoti
02/06/20 Sidoti
ePlus upgraded to Buy from Neutral at Sidoti
11/14/19 Sidoti
ePlus downgraded to Neutral from Buy at Sidoti
NAVB Navidea
$1.32 /

+0.06 (+4.76%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
USFD US Foods
$18.56 /

-0.24 (-1.28%)

05/18/20 Guggenheim
US Foods price target lowered to $30 from $50 at Guggenheim
04/27/20 Credit Suisse
US Foods price target lowered to $27 from $47 at Credit Suisse
04/23/20 BMO Capital
US Foods downgraded to Market Perform from Outperform at BMO Capital
04/06/20 JPMorgan
US Foods price target lowered to $24 from $45 at JPMorgan
NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

04/24/20 Credit Suisse
New York Mortgage upgraded to Neutral from Underperform at Credit Suisse
04/24/20 Credit Suisse
New York Mortgage upgraded to Neutral from Underperform at Credit Suisse
03/25/20 Maxim
AGNC Investment, New York Mortgage Trust cut to Hold at Maxim
03/25/20 Maxim
New York Mortgage downgraded to Hold from Buy at Maxim
AGYS Agilysys
$20.11 /

+0.79 (+4.09%)

04/16/20 BTIG
Agilysys initiated with a Neutral at BTIG
03/16/20 Craig-Hallum
Agilysys price target lowered to $27 from $40 at Craig-Hallum
01/29/20 Craig-Hallum
Agilysys price target raised to $40 from $32 at Craig-Hallum
12/03/19 Craig-Hallum
Agilysys initiated with a Buy at Craig-Hallum
HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

05/19/20 Barclays
Barclays lowers estimates in IT hardware after April survey
04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
04/27/20 Loop Capital
HP Enterprise downgraded to Hold from Buy at Loop Capital
04/22/20
Fly Intel: Top five analyst initiations
LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

04/27/20 RBC Capital
Lionsgate initiated with a Sector Perform at RBC Capital
04/22/20 Deutsche Bank
Lionsgate price target lowered to $10 from $22 at Deutsche Bank
04/21/20 JPMorgan
Lionsgate price target lowered to $11 from $14 at JPMorgan
03/23/20
Lionsgate participates in a conference call with SunTrust
ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

05/19/20 Jefferies
TJX to benefit from 'biggest liquidation sale in history,' says Jefferies
05/11/20 Nomura Instinet
Ross Stores price target raised to $100 from $80 at Nomura Instinet
04/28/20 DA Davidson
Ross Stores upgraded to Buy from Neutral at DA Davidson
04/28/20 DA Davidson
Ross Stores upgraded to Buy from Neutral at DA Davidson
INTU Intuit
$290.30 /

-0.4 (-0.14%)

05/19/20 KeyBanc
Intuit price target raised to $315 from $285 at KeyBanc
05/05/20 KeyBanc
Intuit price target raised to $285 from $275 at KeyBanc
04/17/20 RBC Capital
Intuit lowered to $280 from $345 at RBC Capital
04/13/20 Jefferies
Jefferies continues to like Intuit after approval for small business lending
CHUY Chuy's
$16.13 /

+0.09 (+0.56%)

04/23/20 BMO Capital
Chuy's upgraded to Market Perform from Underperform at BMO Capital
04/20/20 Raymond James
Chuy's price target raised to $17 from $14 at Raymond James
04/08/20 Wedbush
Chuy's price target lowered to $17 from $26 at Wedbush
04/02/20 Raymond James
Chuy's upgraded to Outperform from Market Perform at Raymond James
NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

05/21/20 Credit Suisse
Nvidia reinstated with an Outperform at Credit Suisse
05/19/20 RBC Capital
Nvidia price target raised to $385 from $350 at RBC Capital
05/19/20 Susquehanna
Nvidia price target raised to $410 from $355 at Susquehanna
05/18/20
Fly Intel: Top five analyst upgrades
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
05/11/20 H.C. Wainwright
Syndax price target raised to $25 from $19 at H.C. Wainwright
05/08/20 Nomura Instinet
Syndax price target raised to $31 from $16 at Nomura Instinet
05/04/20 Baird
Syndax risk/reward solid following positive clinical data, says Baird
GERN Geron
$1.95 /

+0.06 (+3.17%)

11/19/19 B. Riley FBR
B. Riley FBR resumes Geron with Buy rating, $4 price target
11/19/19 B. Riley FBR
Geron resumed with a Buy at B. Riley FBR
09/03/19 H.C. Wainwright
Geron initiated with a Buy at H.C. Wainwright
08/15/19 Cantor Fitzgerald
Geron initiated with an Overweight at Cantor Fitzgerald
CFRX ContraFect
$5.38 /

-0.22 (-3.93%)

10/02/19 Piper Sandler
Piper says design differentiates ContraFect trial from other antibiotic studies
06/11/19 Maxim
ContraFect initiated with a Buy at Maxim
DSS Document Security
$8.50 /

+0.22 (+2.66%)

10/10/19 Aegis
Document Security initiated with a Buy rating at Aegis
H Hyatt
$53.45 /

-0.49 (-0.91%)

05/08/20
Fly Intel: Top five analyst downgrades
05/08/20 Deutsche Bank
Hyatt price target lowered to $54 from $86 at Deutsche Bank
05/08/20 Macquarie
Hyatt downgraded to Neutral from Outperform at Macquarie
04/22/20 BofA
Choice Hotels upgraded to Neutral from Underperform at Bofa
USFD US Foods
$18.56 /

-0.24 (-1.28%)

SPLK Splunk
$163.27 /

+0.11 (+0.07%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

RAMP LiveRamp
$38.70 /

-0.16 (-0.41%)

PRSP Perspecta
$22.93 /

-0.4 (-1.71%)

PLUS ePlus
$76.14 /

+4.14 (+5.75%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

GERN Geron
$1.95 /

+0.06 (+3.17%)

ELF e.l.f. Beauty
$14.56 /

+0.34 (+2.39%)

DSS Document Security
$8.50 /

+0.22 (+2.66%)

DECK Deckers Brands
$167.93 /

+5.83 (+3.60%)

CRMT America's Car-Mart
$73.77 /

+2.825 (+3.98%)

CHUY Chuy's
$16.13 /

+0.09 (+0.56%)

CFRX ContraFect
$5.38 /

-0.22 (-3.93%)

AGYS Agilysys
$20.11 /

+0.79 (+4.09%)

A Agilent
$80.84 /

-0.83 (-1.02%)

  • 22
    May
  • 22
    May
  • 22
    May
ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

A Agilent
$80.84 /

-0.83 (-1.02%)

USFD US Foods
$18.56 /

-0.24 (-1.28%)

SPLK Splunk
$163.27 /

+0.11 (+0.07%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

RAMP LiveRamp
$38.70 /

-0.16 (-0.41%)

PRSP Perspecta
$22.93 /

-0.4 (-1.71%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

ELF e.l.f. Beauty
$14.56 /

+0.34 (+2.39%)

DECK Deckers Brands
$167.93 /

+5.83 (+3.60%)

CHUY Chuy's
$16.13 /

+0.09 (+0.56%)

A Agilent
$80.84 /

-0.83 (-1.02%)

SPLK Splunk
$163.27 /

+0.11 (+0.07%)

ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

A Agilent
$80.84 /

-0.83 (-1.02%)

Hot Stocks
Agilent up 5% to $84.70 after Q2 results beat estimates  16:47
05/21/20
05/21
16:47
05/21/20
16:47
A

Agilent

$80.84 /

-0.83 (-1.02%)

 
ShowHide Related Items >><<
A Agilent
$80.84 /

-0.83 (-1.02%)

A Agilent
$80.84 /

-0.83 (-1.02%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
A Agilent
$80.84 /

-0.83 (-1.02%)

A Agilent
$80.84 /

-0.83 (-1.02%)

A Agilent
$80.84 /

-0.83 (-1.02%)

A Agilent
$80.84 /

-0.83 (-1.02%)

Earnings
Agilent reports Q2 adjusted EPS 71c, consensus 61c » 16:09
05/21/20
05/21
16:09
05/21/20
16:09
A

Agilent

$80.77 /

-0.9 (-1.10%)

Reports Q2 revenue…

Reports Q2 revenue $1.24B, consensus $1.21B. "Our business was tracking well into late March when we experienced significant disruption in the U.S. and Europe as customers closed or restricted access to their facilities to slow the spread of COVID-19," said Mike McMullen, Agilent president and CEO. "I'm incredibly proud of how the Agilent team has taken quick, decisive action to ensure the safety of our employees, keep our operations up and running efficiently, and support our customers around the world. I believe we are well-positioned to face the challenges brought on by COVID-19 given our focus on growth, a resilient business model, a strong balance sheet, and most importantly, our outstanding team."

ShowHide Related Items >><<
A Agilent
$80.77 /

-0.9 (-1.10%)

A Agilent
$80.77 /

-0.9 (-1.10%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
A Agilent
$80.77 /

-0.9 (-1.10%)

A Agilent
$80.77 /

-0.9 (-1.10%)

A Agilent
$80.77 /

-0.9 (-1.10%)

A Agilent
$80.77 /

-0.9 (-1.10%)

Hot Stocks
Agilent PD-L1 assay receives FDA approval for use as companion diagnostic » 08:08
05/18/20
05/18
08:08
05/18/20
08:08
A

Agilent

$81.52 /

-0.07 (-0.09%)

, BMY

Bristol-Myers

$64.19 /

+0.38 (+0.60%)

Agilent Technologies (A)…

Agilent Technologies (A) announced that the FDA has approved the company's PD-L1 IHC 28-8 pharmDx for expanded use in non-small cell lung cancer, or NSCLC. Agilent developed PD-L1 IHC 28-8 pharmDx in 2016 through a collaboration with Bristol Myers Squibb (BMY), and it has been previously approved as a complementary in vitro diagnostic for non-squamous non-small cell lung cancer, as well as other forms of cancer, including, squamous cell carcinoma of the head and neck, and urothelial carcinoma.

ShowHide Related Items >><<
BMY Bristol-Myers
$64.19 /

+0.38 (+0.60%)

A Agilent
$81.52 /

-0.07 (-0.09%)

A Agilent
$81.52 /

-0.07 (-0.09%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
BMY Bristol-Myers
$64.19 /

+0.38 (+0.60%)

05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
BMY Bristol-Myers
$64.19 /

+0.38 (+0.60%)

A Agilent
$81.52 /

-0.07 (-0.09%)

BMY Bristol-Myers
$64.19 /

+0.38 (+0.60%)

A Agilent
$81.52 /

-0.07 (-0.09%)

BMY Bristol-Myers
$64.19 /

+0.38 (+0.60%)

A Agilent
$81.52 /

-0.07 (-0.09%)

BMY Bristol-Myers
$64.19 /

+0.38 (+0.60%)

A Agilent
$81.52 /

-0.07 (-0.09%)

Hot Stocks
Ackman's Pershing Square adds Blackstone, cuts Chipotle in Q1 » 16:42
05/15/20
05/15
16:42
05/15/20
16:42
BX

Blackstone

$51.10 /

+0.53 (+1.05%)

, PK

Park Hotels & Resorts

$7.32 /

+ (+0.00%)

, A

Agilent

$81.52 /

-0.07 (-0.09%)

, HHC

Howard Hughes

$42.58 /

-1.24 (-2.83%)

, SBUX

Starbucks

$74.16 /

-0.08 (-0.11%)

, BRK.B

Berkshire Hathaway

$169.41 /

-1.5 (-0.88%)

, LOW

Lowe's

$113.87 /

+3.46 (+3.13%)

, CMG

Chipotle

$973.22 /

+42.01 (+4.51%)

, HLT

Hilton

$68.63 /

+0.52 (+0.76%)

Bill Ackman's…

Bill Ackman's Pershing Square Capital disclosed in an SEC filing its holdings as of March 31, 2020. The fund's two new buys during the first quarter included, by size of position, Blackstone (BX) and Park Hotels & Resorts (PK). Pershing increased its stake in six positions during the quarter, including by size of previous position Agilent (A), Howard Hughes (HHC), Starbucks (SBUX), Berkshire Hathaway Class B (BRK.B), and Lowe's (LOW). The fund decreased its stake in one holding, namely Chipotle (CMG). Pershing's top holdings as of March 31, in order of size, were Lowe's, Berkshire Hathaway Class B, Hilton Worldwide (HLT), Agilent, and Chipotle.

ShowHide Related Items >><<
SBUX Starbucks
$74.16 /

-0.08 (-0.11%)

PK Park Hotels & Resorts
$7.32 /

+ (+0.00%)

LOW Lowe's
$113.87 /

+3.46 (+3.13%)

HLT Hilton
$68.63 /

+0.52 (+0.76%)

HHC Howard Hughes
$42.58 /

-1.24 (-2.83%)

CMG Chipotle
$973.22 /

+42.01 (+4.51%)

BX Blackstone
$51.10 /

+0.53 (+1.05%)

BRK.B Berkshire Hathaway
$169.41 /

-1.5 (-0.88%)

A Agilent
$81.52 /

-0.07 (-0.09%)

BX Blackstone
$51.10 /

+0.53 (+1.05%)

04/24/20 Citi
Blackstone price target raised to $57.50 from $53.50 at Citi
04/15/20 Wells Fargo
Blackstone price target lowered to $62 from $70 at Wells Fargo
04/14/20 Nomura Instinet
Alnylam risks not absolved with Blackstone deal, says Nomura Instinet
03/19/20 Citi
Blackstone upgraded to Buy from Neutral at Citi
PK Park Hotels & Resorts
$7.32 /

+ (+0.00%)

04/07/20 Wells Fargo
Park Hotels & Resorts downgraded to Underweight from Equal Weight at Wells Fargo
04/07/20 Citi
Park Hotels & Resorts downgraded to Sell from Neutral at Citi
03/30/20 Jefferies
Jefferies upgrades Host and Sunstone, downgrades Park Hotels in REIT reorg
03/30/20 Jefferies
Park Hotels & Resorts downgraded to Hold from Buy at Jefferies
A Agilent
$81.52 /

-0.07 (-0.09%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
HHC Howard Hughes
$42.58 /

-1.24 (-2.83%)

03/31/20 BWS Financial
Howard Hughes price target lowered to $80 from $150 at BWS Financial
03/26/20
Fly Intel: Top five analyst downgrades
03/26/20 Piper Sandler
Howard Hughes downgraded to Neutral from Overweight at Piper Sandler
12/31/19 BWS Financial
Howard Hughes share price not reflective of cash flow power, says BWS Financial
SBUX Starbucks
$74.16 /

-0.08 (-0.11%)

04/29/20 JPMorgan
Starbucks shares have 'overshot' near-term results, says JPMorgan
04/29/20 Stephens
Starbucks price target lowered to $72 from $80 at Stephens
04/29/20 Piper Sandler
Piper Sandler still 'paused' on Starbucks shares after Q1 results
04/29/20 Barclays
Starbucks price target lowered to $92 from $97 at Barclays
BRK.B Berkshire Hathaway
$169.41 /

-1.5 (-0.88%)

LOW Lowe's
$113.87 /

+3.46 (+3.13%)

05/14/20
Fly Intel: Top five analyst downgrades
05/14/20 Cleveland Research
Homecenters had strong end of April, start to May, says Cleveland Research
05/14/20 Evercore ISI
Lowe's downgraded to In Line from Outperform at Evercore ISI
05/12/20 Wells Fargo
Lowe's price target raised to $130 from $110 at Wells Fargo
CMG Chipotle
$973.22 /

+42.01 (+4.51%)

05/14/20 Piper Sandler
Chipotle price target raised to $1,100 from $850 at Piper Sandler
04/24/20 Stifel
Papa John's price target raised to $80 from $65 at Stifel
04/23/20
Fly Intel: Top five analyst upgrades
04/23/20 RBC Capital
Chipotle price target raised to $783 from $727 at RBC Capital
HLT Hilton
$68.63 /

+0.52 (+0.76%)

05/11/20 Raymond James
Hilton price target raised to $82 from $77 at Raymond James
05/08/20 Deutsche Bank
Hilton price target lowered to $74 from $103 at Deutsche Bank
04/22/20 BofA
Choice Hotels upgraded to Neutral from Underperform at Bofa
04/14/20 Barclays
Investors should start preparing to buy lodging stocks, says Barclays
SBUX Starbucks
$74.16 /

-0.08 (-0.11%)

PK Park Hotels & Resorts
$7.32 /

+ (+0.00%)

LOW Lowe's
$113.87 /

+3.46 (+3.13%)

HLT Hilton
$68.63 /

+0.52 (+0.76%)

HHC Howard Hughes
$42.58 /

-1.24 (-2.83%)

CMG Chipotle
$973.22 /

+42.01 (+4.51%)

BX Blackstone
$51.10 /

+0.53 (+1.05%)

BRK.B Berkshire Hathaway
$169.41 /

-1.5 (-0.88%)

A Agilent
$81.52 /

-0.07 (-0.09%)

SBUX Starbucks
$74.16 /

-0.08 (-0.11%)

HLT Hilton
$68.63 /

+0.52 (+0.76%)

CMG Chipotle
$973.22 /

+42.01 (+4.51%)

BX Blackstone
$51.10 /

+0.53 (+1.05%)

BRK.B Berkshire Hathaway
$169.41 /

-1.5 (-0.88%)

A Agilent
$81.52 /

-0.07 (-0.09%)

SBUX Starbucks
$74.16 /

-0.08 (-0.11%)

LOW Lowe's
$113.87 /

+3.46 (+3.13%)

HLT Hilton
$68.63 /

+0.52 (+0.76%)

HHC Howard Hughes
$42.58 /

-1.24 (-2.83%)

CMG Chipotle
$973.22 /

+42.01 (+4.51%)

BX Blackstone
$51.10 /

+0.53 (+1.05%)

BRK.B Berkshire Hathaway
$169.41 /

-1.5 (-0.88%)

A Agilent
$81.52 /

-0.07 (-0.09%)

SBUX Starbucks
$74.16 /

-0.08 (-0.11%)

PK Park Hotels & Resorts
$7.32 /

+ (+0.00%)

LOW Lowe's
$113.87 /

+3.46 (+3.13%)

HLT Hilton
$68.63 /

+0.52 (+0.76%)

CMG Chipotle
$973.22 /

+42.01 (+4.51%)

BX Blackstone
$51.10 /

+0.53 (+1.05%)

A Agilent
$81.52 /

-0.07 (-0.09%)

Hot Stocks
FDA approves Agilent PD-L1 diagnostic device for lung cancer » 14:25
05/15/20
05/15
14:25
05/15/20
14:25
A

Agilent

$81.55 /

-0.04 (-0.05%)

the Food and Drug…

the Food and Drug Administration today approved the PD-L1 IHC 28-8 pharmDx from Agilent Technologies as a companion diagnostic device for selecting patients with metastatic non-small cell lung cancer for treatment with nivolumab plus ipilimumab. Reference Link

ShowHide Related Items >><<
A Agilent
$81.55 /

-0.04 (-0.05%)

A Agilent
$81.55 /

-0.04 (-0.05%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
A Agilent
$81.55 /

-0.04 (-0.05%)

A Agilent
$81.55 /

-0.04 (-0.05%)

A Agilent
$81.55 /

-0.04 (-0.05%)

A Agilent
$81.55 /

-0.04 (-0.05%)

Conference/Events
American Society of Gene & Cell Therapy to hold virtual meeting » 05:55
05/15/20
05/15
05:55
05/15/20
05:55
A

Agilent

$81.59 /

+1.44 (+1.80%)

, ABEO

Abeona Therapeutics

$3.21 /

-0.065 (-1.98%)

, ADVM

Adverum Biotechnologies

$17.20 /

-0.18 (-1.04%)

, AGEEF

Halo Labs

$0.00 /

+ (+0.00%)

, AVRO

Avrobio

$15.58 /

-1.19 (-7.10%)

, BIO

Bio-Rad

$455.80 /

+2.52 (+0.56%)

, BMRN

BioMarin

$91.67 /

-3.01 (-3.18%)

, CRL

Charles River

$163.30 /

+3.07 (+1.92%)

, CTLT

Catalent

$70.04 /

-1.08 (-1.52%)

, MGTA

Magenta Therapeutics

$8.67 /

-0.305 (-3.40%)

, PI

Impinj

$22.94 /

+1.01 (+4.61%)

, QURE

uniQure

$56.16 /

-0.56 (-0.99%)

, SRPT

Sarepta

$127.15 /

-1.08 (-0.84%)

, TECH

Bio-Techne

$261.68 /

-0.7 (-0.27%)

, TMO

Thermo Fisher

$336.49 /

+2.31 (+0.69%)

, RARE

Ultragenyx

$64.57 /

+0.44 (+0.69%)

23rd Annual Virtual…

23rd Annual Virtual Meeting of ASGCT 2020 will be held May 12-15. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$336.49 /

+2.31 (+0.69%)

TECH Bio-Techne
$261.68 /

-0.7 (-0.27%)

SRPT Sarepta
$127.15 /

-1.08 (-0.84%)

RARE Ultragenyx
$64.57 /

+0.44 (+0.69%)

QURE uniQure
$56.16 /

-0.56 (-0.99%)

PI Impinj
$22.94 /

+1.01 (+4.61%)

MGTA Magenta Therapeutics
$8.67 /

-0.305 (-3.40%)

CTLT Catalent
$70.04 /

-1.08 (-1.52%)

CRL Charles River
$163.30 /

+3.07 (+1.92%)

BMRN BioMarin
$91.67 /

-3.01 (-3.18%)

BIO Bio-Rad
$455.80 /

+2.52 (+0.56%)

AVRO Avrobio
$15.58 /

-1.19 (-7.10%)

ADVM Adverum Biotechnologies
$17.20 /

-0.18 (-1.04%)

ABEO Abeona Therapeutics
$3.21 /

-0.065 (-1.98%)

A Agilent
$81.59 /

+1.44 (+1.80%)

A Agilent
$81.59 /

+1.44 (+1.80%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
ABEO Abeona Therapeutics
$3.21 /

-0.065 (-1.98%)

05/08/20 Jefferies
Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies
12/30/19 H.C. Wainwright
Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
12/20/19 Cantor Fitzgerald
Abeona financing to lessen takeover chartter, says Cantor Fitzgerald
12/10/19 Cantor Fitzgerald
Abeona Therapeutics assumed with a Neutral at Cantor Fitzgerald
ADVM Adverum Biotechnologies
$17.20 /

-0.18 (-1.04%)

05/12/20 RBC Capital
Adverum Biotechnologies initiated with an Outperform at RBC Capital
05/05/20 SunTrust
Adverum Biotechnologies upgraded to Buy from Hold at SunTrust
05/05/20 SunTrust
Adverum Biotechnologies upgraded to Buy from Hold at SunTrust
04/28/20 Goldman Sachs
Adverum Biotechnologies initiated with a Buy at Goldman Sachs
AGEEF Halo Labs
$0.00 /

+ (+0.00%)

AVRO Avrobio
$15.58 /

-1.19 (-7.10%)

03/31/20 H.C. Wainwright
Avrobio downgraded to Neutral from Buy at H.C. Wainwright
03/17/20 Janney Montgomery Scott
Avrobio weakness a buying opportunity, says Janney Montgomery Scott
02/19/20 Nomura Instinet
Avrobio price target raised to $50 from $35 at Nomura Instinet
02/11/20 Mizuho
Avrobio price target raised to $35 from $28 at Mizuho
BIO Bio-Rad
$455.80 /

+2.52 (+0.56%)

04/08/20 Jefferies
Bio-Rad COVID-19 antibody test 'could be big,' says Jefferies
03/03/20 Citi
Bio-Rad margin expansion story in early innings, says Citi
01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Bio-Rad initiated with an Overweight at Wells Fargo
BMRN BioMarin
$91.67 /

-3.01 (-3.18%)

05/08/20 Canaccord
BioMarin price target raised to $119 from $108 at Canaccord
05/01/20 Jefferies
Jefferies says valrox, vosoritide uptake may be faster than other BioMarin drugs
04/29/20 Piper Sandler
BioMarin guidance cut 'transient', says Piper Sandler
04/06/20
BioMarin participates in a conference call with Stifel
CRL Charles River
$163.30 /

+3.07 (+1.92%)

05/13/20 UBS
Charles River upgraded to Buy from Neutral at UBS
05/08/20 Baird
Charles River price target raised to $175 from $156 at Baird
05/08/20 SunTrust
Charles River price target raised to $194 from $130 at SunTrust
04/21/20 Jefferies
Jefferies downgrades Charles River to Hold after 51% rally from lows
CTLT Catalent
$70.04 /

-1.08 (-1.52%)

05/06/20 Baird
Catalent price target raised to $74 from $63 at Baird
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/20/20 RBC Capital
Catalent initiated with an Outperform at RBC Capital
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
MGTA Magenta Therapeutics
$8.67 /

-0.305 (-3.40%)

01/15/20 BTIG
BTIG sees 'no real reason' for Magenta Therapeutics sell-off
12/06/19 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
12/06/19 Goldman Sachs
Magenta Therapeutics assumed with a Neutral at Goldman Sachs
PI Impinj
$22.94 /

+1.01 (+4.61%)

04/28/20 Needham
Impinj price target raised to $25 from $19 at Needham
04/28/20 Canaccord
Impinj price target lowered to $35 from $40 at Canaccord
04/27/20 Piper Sandler
Impinj price target lowered to $29 from $44 at Piper Sandler
03/10/20 Morgan Stanley
Morgan Stanley lowers semiconductor estimates to reflect COVID-19 disruption
QURE uniQure
$56.16 /

-0.56 (-0.99%)

03/26/20 Piper Sandler
uniQure trial delay 'comes as no surprise,' says Piper Sandler
01/23/20 Cantor Fitzgerald
Cantor sees further upside in uniQure, calls 'highly attractive' buyout candiate
12/10/19 Mizuho
uniQure price target raised to $90 from $67 at Mizuho
12/09/19 Piper Sandler
Piper says uniQure solidified 'front runner' position in Hemophilia B at ASH
SRPT Sarepta
$127.15 /

-1.08 (-0.84%)

05/07/20 Nomura Instinet
Nomura sees double in Sarepta shares, says buy on earnings selloff
04/28/20 JMP Securities
JMP cautious on feasibility of Sarepta PPMO constructs being used in COVID fight
04/27/20 Citi
Sarepta upcoming PPMO readout unlikely to be catalyst, says Citi
03/30/20 Mizuho
Sarepta initiated with a Buy at Mizuho
TECH Bio-Techne
$261.68 /

-0.7 (-0.27%)

05/14/20 Benchmark
Benchmark sees 'multiple ways to play COVID-19' for Bio-Techne, starts at Buy
05/14/20 Benchmark
Bio-Techne initiated with a Buy at Benchmark
04/20/20 Craig-Hallum
Bio-Techne price target lowered to $211 from $218 at Craig-Hallum
03/30/20 Wells Fargo
Bio-Techne price target lowered to $190 from $225 at Wells Fargo
TMO Thermo Fisher
$336.49 /

+2.31 (+0.69%)

04/23/20 SVB Leerink
Thermo Fisher price target raised to $365 from $330 at SVB Leerink
04/23/20 Needham
Thermo Fisher price target raised to $383 from $341 at Needham
04/21/20 Wells Fargo
Danaher price target raised to $170 from $155 at Wells Fargo
03/30/20 Wells Fargo
Thermo Fisher price target lowered to $300 from $345 at Wells Fargo
RARE Ultragenyx
$64.57 /

+0.44 (+0.69%)

05/13/20 Piper Sandler
Ultragenyx DTX-301 update 'incrementally positive,' says Piper Sandler
01/10/20 SunTrust
Ultragenyx price target raised to $80 from $75 at SunTrust
01/10/20 Piper Sandler
Ultragenyx gene therapy update 'surprisingly positive,' says Piper Sandler
12/18/19 Piper Sandler
Piper remains buyer of Ultragenyx after Royalty Pharma deal
TMO Thermo Fisher
$336.49 /

+2.31 (+0.69%)

TECH Bio-Techne
$261.68 /

-0.7 (-0.27%)

SRPT Sarepta
$127.15 /

-1.08 (-0.84%)

RARE Ultragenyx
$64.57 /

+0.44 (+0.69%)

QURE uniQure
$56.16 /

-0.56 (-0.99%)

PI Impinj
$22.94 /

+1.01 (+4.61%)

MGTA Magenta Therapeutics
$8.67 /

-0.305 (-3.40%)

CTLT Catalent
$70.04 /

-1.08 (-1.52%)

CRL Charles River
$163.30 /

+3.07 (+1.92%)

BMRN BioMarin
$91.67 /

-3.01 (-3.18%)

BIO Bio-Rad
$455.80 /

+2.52 (+0.56%)

AVRO Avrobio
$15.58 /

-1.19 (-7.10%)

ADVM Adverum Biotechnologies
$17.20 /

-0.18 (-1.04%)

ABEO Abeona Therapeutics
$3.21 /

-0.065 (-1.98%)

A Agilent
$81.59 /

+1.44 (+1.80%)

TMO Thermo Fisher
$336.49 /

+2.31 (+0.69%)

SRPT Sarepta
$127.15 /

-1.08 (-0.84%)

CTLT Catalent
$70.04 /

-1.08 (-1.52%)

A Agilent
$81.59 /

+1.44 (+1.80%)

TMO Thermo Fisher
$336.49 /

+2.31 (+0.69%)

SRPT Sarepta
$127.15 /

-1.08 (-0.84%)

PI Impinj
$22.94 /

+1.01 (+4.61%)

BMRN BioMarin
$91.67 /

-3.01 (-3.18%)

ADVM Adverum Biotechnologies
$17.20 /

-0.18 (-1.04%)

A Agilent
$81.59 /

+1.44 (+1.80%)

TMO Thermo Fisher
$336.49 /

+2.31 (+0.69%)

SRPT Sarepta
$127.15 /

-1.08 (-0.84%)

QURE uniQure
$56.16 /

-0.56 (-0.99%)

PI Impinj
$22.94 /

+1.01 (+4.61%)

BMRN BioMarin
$91.67 /

-3.01 (-3.18%)

A Agilent
$81.59 /

+1.44 (+1.80%)

Conference/Events
American Society of Gene & Cell Therapy to hold virtual meeting » 04:55
05/14/20
05/14
04:55
05/14/20
04:55
A

Agilent

$80.15 /

+0.32 (+0.40%)

, ABEO

Abeona Therapeutics

$3.28 /

+0.235 (+7.73%)

, ADVM

Adverum Biotechnologies

$17.38 /

-1.4 (-7.45%)

, AGEEF

Halo Labs

$0.00 /

+ (+0.00%)

, AVRO

Avrobio

$16.77 /

-0.22 (-1.29%)

, BIO

Bio-Rad

$453.28 /

-8.19 (-1.77%)

, BMRN

BioMarin

$94.68 /

-1.49 (-1.55%)

, CRL

Charles River

$160.23 /

-1.16 (-0.72%)

, CTLT

Catalent

$71.12 /

+ (+0.00%)

, MGTA

Magenta Therapeutics

$8.98 /

-0.4 (-4.27%)

, PI

Impinj

$21.93 /

-1.94 (-8.13%)

, QURE

uniQure

$56.72 /

-4.33 (-7.09%)

, SRPT

Sarepta

$128.23 /

-4.5 (-3.39%)

, TECH

Bio-Techne

$262.38 /

-10.54 (-3.86%)

, TMO

Thermo Fisher

$334.18 /

+2.23 (+0.67%)

, RARE

Ultragenyx

$64.13 /

-2.07 (-3.13%)

23rd Annual Virtual…

23rd Annual Virtual Meeting of ASGCT 2020 will be held May 12-15. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$334.18 /

+2.23 (+0.67%)

TECH Bio-Techne
$262.38 /

-10.54 (-3.86%)

SRPT Sarepta
$128.23 /

-4.5 (-3.39%)

RARE Ultragenyx
$64.13 /

-2.07 (-3.13%)

QURE uniQure
$56.72 /

-4.33 (-7.09%)

PI Impinj
$21.93 /

-1.94 (-8.13%)

MGTA Magenta Therapeutics
$8.98 /

-0.4 (-4.27%)

CTLT Catalent
$71.12 /

+ (+0.00%)

CRL Charles River
$160.23 /

-1.16 (-0.72%)

BMRN BioMarin
$94.68 /

-1.49 (-1.55%)

BIO Bio-Rad
$453.28 /

-8.19 (-1.77%)

AVRO Avrobio
$16.77 /

-0.22 (-1.29%)

ADVM Adverum Biotechnologies
$17.38 /

-1.4 (-7.45%)

ABEO Abeona Therapeutics
$3.28 /

+0.235 (+7.73%)

A Agilent
$80.15 /

+0.32 (+0.40%)

A Agilent
$80.15 /

+0.32 (+0.40%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
ABEO Abeona Therapeutics
$3.28 /

+0.235 (+7.73%)

05/08/20 Jefferies
Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies
12/30/19 H.C. Wainwright
Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
12/20/19 Cantor Fitzgerald
Abeona financing to lessen takeover chartter, says Cantor Fitzgerald
12/10/19 Cantor Fitzgerald
Abeona Therapeutics assumed with a Neutral at Cantor Fitzgerald
ADVM Adverum Biotechnologies
$17.38 /

-1.4 (-7.45%)

05/12/20 RBC Capital
Adverum Biotechnologies initiated with an Outperform at RBC Capital
05/05/20 SunTrust
Adverum Biotechnologies upgraded to Buy from Hold at SunTrust
05/05/20 SunTrust
Adverum Biotechnologies upgraded to Buy from Hold at SunTrust
04/28/20 Goldman Sachs
Adverum Biotechnologies initiated with a Buy at Goldman Sachs
AGEEF Halo Labs
$0.00 /

+ (+0.00%)

AVRO Avrobio
$16.77 /

-0.22 (-1.29%)

03/31/20 H.C. Wainwright
Avrobio downgraded to Neutral from Buy at H.C. Wainwright
03/17/20 Janney Montgomery Scott
Avrobio weakness a buying opportunity, says Janney Montgomery Scott
02/19/20 Nomura Instinet
Avrobio price target raised to $50 from $35 at Nomura Instinet
02/11/20 Mizuho
Avrobio price target raised to $35 from $28 at Mizuho
BIO Bio-Rad
$453.28 /

-8.19 (-1.77%)

04/08/20 Jefferies
Bio-Rad COVID-19 antibody test 'could be big,' says Jefferies
03/03/20 Citi
Bio-Rad margin expansion story in early innings, says Citi
01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Bio-Rad initiated with an Overweight at Wells Fargo
BMRN BioMarin
$94.68 /

-1.49 (-1.55%)

05/08/20 Canaccord
BioMarin price target raised to $119 from $108 at Canaccord
05/01/20 Jefferies
Jefferies says valrox, vosoritide uptake may be faster than other BioMarin drugs
04/29/20 Piper Sandler
BioMarin guidance cut 'transient', says Piper Sandler
04/06/20
BioMarin participates in a conference call with Stifel
CRL Charles River
$160.23 /

-1.16 (-0.72%)

05/13/20 UBS
Charles River upgraded to Buy from Neutral at UBS
05/08/20 Baird
Charles River price target raised to $175 from $156 at Baird
05/08/20 SunTrust
Charles River price target raised to $194 from $130 at SunTrust
04/21/20 Jefferies
Jefferies downgrades Charles River to Hold after 51% rally from lows
CTLT Catalent
$71.12 /

+ (+0.00%)

05/06/20 Baird
Catalent price target raised to $74 from $63 at Baird
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/20/20 RBC Capital
Catalent initiated with an Outperform at RBC Capital
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
MGTA Magenta Therapeutics
$8.98 /

-0.4 (-4.27%)

01/15/20 BTIG
BTIG sees 'no real reason' for Magenta Therapeutics sell-off
12/06/19 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
12/06/19 Goldman Sachs
Magenta Therapeutics assumed with a Neutral at Goldman Sachs
PI Impinj
$21.93 /

-1.94 (-8.13%)

04/28/20 Needham
Impinj price target raised to $25 from $19 at Needham
04/28/20 Canaccord
Impinj price target lowered to $35 from $40 at Canaccord
04/27/20 Piper Sandler
Impinj price target lowered to $29 from $44 at Piper Sandler
03/10/20 Morgan Stanley
Morgan Stanley lowers semiconductor estimates to reflect COVID-19 disruption
QURE uniQure
$56.72 /

-4.33 (-7.09%)

03/26/20 Piper Sandler
uniQure trial delay 'comes as no surprise,' says Piper Sandler
01/23/20 Cantor Fitzgerald
Cantor sees further upside in uniQure, calls 'highly attractive' buyout candiate
12/10/19 Mizuho
uniQure price target raised to $90 from $67 at Mizuho
12/09/19 Piper Sandler
Piper says uniQure solidified 'front runner' position in Hemophilia B at ASH
SRPT Sarepta
$128.23 /

-4.5 (-3.39%)

05/07/20 Nomura Instinet
Nomura sees double in Sarepta shares, says buy on earnings selloff
04/28/20 JMP Securities
JMP cautious on feasibility of Sarepta PPMO constructs being used in COVID fight
04/27/20 Citi
Sarepta upcoming PPMO readout unlikely to be catalyst, says Citi
03/30/20 Mizuho
Sarepta initiated with a Buy at Mizuho
TECH Bio-Techne
$262.38 /

-10.54 (-3.86%)

04/20/20 Craig-Hallum
Bio-Techne price target lowered to $211 from $218 at Craig-Hallum
03/30/20 Wells Fargo
Bio-Techne price target lowered to $190 from $225 at Wells Fargo
02/24/20 Eight Capital
Bio-Techne downgraded to Neutral from Buy at Eight Capital
01/08/20 Stephens
Bio-Techne resumed with an Overweight at Stephens
TMO Thermo Fisher
$334.18 /

+2.23 (+0.67%)

04/23/20 SVB Leerink
Thermo Fisher price target raised to $365 from $330 at SVB Leerink
04/23/20 Needham
Thermo Fisher price target raised to $383 from $341 at Needham
04/21/20 Wells Fargo
Danaher price target raised to $170 from $155 at Wells Fargo
03/30/20 Wells Fargo
Thermo Fisher price target lowered to $300 from $345 at Wells Fargo
RARE Ultragenyx
$64.13 /

-2.07 (-3.13%)

05/13/20 Piper Sandler
Ultragenyx DTX-301 update 'incrementally positive,' says Piper Sandler
01/10/20 SunTrust
Ultragenyx price target raised to $80 from $75 at SunTrust
01/10/20 Piper Sandler
Ultragenyx gene therapy update 'surprisingly positive,' says Piper Sandler
12/18/19 Piper Sandler
Piper remains buyer of Ultragenyx after Royalty Pharma deal
TMO Thermo Fisher
$334.18 /

+2.23 (+0.67%)

TECH Bio-Techne
$262.38 /

-10.54 (-3.86%)

SRPT Sarepta
$128.23 /

-4.5 (-3.39%)

RARE Ultragenyx
$64.13 /

-2.07 (-3.13%)

QURE uniQure
$56.72 /

-4.33 (-7.09%)

PI Impinj
$21.93 /

-1.94 (-8.13%)

MGTA Magenta Therapeutics
$8.98 /

-0.4 (-4.27%)

CTLT Catalent
$71.12 /

+ (+0.00%)

CRL Charles River
$160.23 /

-1.16 (-0.72%)

BMRN BioMarin
$94.68 /

-1.49 (-1.55%)

BIO Bio-Rad
$453.28 /

-8.19 (-1.77%)

AVRO Avrobio
$16.77 /

-0.22 (-1.29%)

ADVM Adverum Biotechnologies
$17.38 /

-1.4 (-7.45%)

ABEO Abeona Therapeutics
$3.28 /

+0.235 (+7.73%)

A Agilent
$80.15 /

+0.32 (+0.40%)

TMO Thermo Fisher
$334.18 /

+2.23 (+0.67%)

SRPT Sarepta
$128.23 /

-4.5 (-3.39%)

CTLT Catalent
$71.12 /

+ (+0.00%)

A Agilent
$80.15 /

+0.32 (+0.40%)

TMO Thermo Fisher
$334.18 /

+2.23 (+0.67%)

SRPT Sarepta
$128.23 /

-4.5 (-3.39%)

PI Impinj
$21.93 /

-1.94 (-8.13%)

BMRN BioMarin
$94.68 /

-1.49 (-1.55%)

ADVM Adverum Biotechnologies
$17.38 /

-1.4 (-7.45%)

A Agilent
$80.15 /

+0.32 (+0.40%)

TMO Thermo Fisher
$334.18 /

+2.23 (+0.67%)

SRPT Sarepta
$128.23 /

-4.5 (-3.39%)

QURE uniQure
$56.72 /

-4.33 (-7.09%)

PI Impinj
$21.93 /

-1.94 (-8.13%)

BMRN BioMarin
$94.68 /

-1.49 (-1.55%)

A Agilent
$80.15 /

+0.32 (+0.40%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.